Today: 15 January 2026
Subscribe

Shan Ahmed Khan

As a journalist focused on finance and the stock market, he delivers fast, reliable, and easy-to-understand coverage of market news.

Sable Offshore Corp (SOC) Stock News Today: PHMSA Clears Las Flores Pipeline Restart — Latest Price, Forecasts, and What Comes Next (Dec. 24, 2025)

Sable Offshore Corp (SOC) Stock News Today: PHMSA Clears Las Flores Pipeline Restart — Latest Price, Forecasts, and What Comes Next (Dec. 24, 2025)

Sable Offshore Corp. (NYSE: SOC) is back in the spotlight on December 24, 2025, after a key federal regulatory decision reignited investor optimism about the company’s ability to restart a long-idled California pipeline system—an outcome that matters because Sable’s business
24 December 2025
···
Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies (DVAX) Stock Jumps on Sanofi’s $2.2B Cash Buyout Offer: Latest News, Forecasts, and What Comes Next (Dec. 24, 2025)

Dynavax Technologies Corporation (NASDAQ: DVAX) is the center of the biotech tape on Wednesday, December 24, 2025, after Sanofi announced a deal to acquire the vaccine maker in an all-cash transaction valued at roughly $2.2 billion. The headline number investors
24 December 2025
····
Multi Ways Holdings Limited (MWG) Stock Jumps on H1 2025 Results: Revenue Up 88%, Profit Improves, and 2026 Infrastructure Outlook in Focus (Dec. 24, 2025)

Multi Ways Holdings Limited (MWG) Stock Jumps on H1 2025 Results: Revenue Up 88%, Profit Improves, and 2026 Infrastructure Outlook in Focus (Dec. 24, 2025)

Multi Ways Holdings Limited (NYSE American: MWG) is suddenly on a lot more traders’ radars on December 24, 2025, after the Singapore-based heavy construction equipment supplier released unaudited first-half 2025 results (six months ended June 30, 2025) and filed the
24 December 2025
····
Moderna Stock (MRNA) Today: Shares Cool Off After a Late-December Spike as Investors Focus on Bird Flu Funding, mNEXSPIKE’s EU Path, and 2026 Growth Targets

Moderna Stock (MRNA) Today: Shares Cool Off After a Late-December Spike as Investors Focus on Bird Flu Funding, mNEXSPIKE’s EU Path, and 2026 Growth Targets

December 24, 2025 — Moderna, Inc. (NASDAQ: MRNA) is ending 2025 with the kind of chart action that makes both traders and long-term biotech investors sit up straight. After a sharp multi-day run, Moderna stock pulled back hard: shares closed
24 December 2025
····
1 … 272 273 274 275 276 … 607
Go toTop